• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

#VisualAbstract: SARS-CoV-2 is associated with higher incidence of Kawasaki disease in children

byConstance Wu
September 23, 2020
in Chronic Disease
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Severe acute respiratory syndrome coronavirus 2 infection increases the rate of Kawasaki disease in children.

2. Individuals with severe Kawasaki disease were more likely to have myocarditis, require combination therapy with inotrope treatment, and require admission to the intensive care unit.

Evidence Rating Level: 2 (Good)

Study Rundown: Viral disease is a known trigger for Kawasaki disease. Epidemiologic data examining the correlation between SARS-CoV-2 infection and the emergence of Kawasaki disease is limited. This quasi-experimental retrospective study examined the link between SaRS-CoV-2 infection and Kawasaki disease at the Robert Debré University Hospital in Paris, France. The number of pediatric patients (aged <18 years) with Kawasaki disease was recorded from December 1, 2005 to May 20, 2020. Results of nasopharyngeal polymerase chain reaction tests from September 2017 to May 2020 were also recorded. Between April 1, 2020 and May 20, 2020, patients diagnosed with Kawasaki disease were tested for SARS-CoV-2 infection. Similar to trends during the influenza A H1N1 pandemic, there was a five-fold increase in Kawasaki disease-related hospitalizations during the COVID-19 pandemic.. However, this was not associated with the total number of hospital admissions, which declined from March 2020. Among hospitalized patients with Kawasaki disease, 8 of 10 tested positive for COVID-19, and the majority required admission to the intensive care unit. This study was limited by a small sample size, with data obtained from a single tertiary care centre, thereby restricting the generalizability of findings. Additionally, because the centre was located in the epi-centre of a COVID-19 outbreak, the association between SARS-CoV-2 infection and Kawasaki disease may have been overestimated. Nonetheless, this study may have important clinical implications in terms of an expected increase in incidence of severe Kawasaki disease with ongoing SARS-CoV-2 transmission.

Click here to read the study in The Lancet Child & Adolescent Health

Relevant Reading: Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

In-depth [retrospective cohort]: This quasi-experimental study analyzed the number of patients (aged <18 years) who were admitted with Kawasaki disease to the Robert Debré University Hospital from Dec 1, 2005 to May 20, 2020. Individuals diagnosed with Kawasaki disease after April 1, 2020 were tested for SARS-CoV-2 serology. The number of monthly Kawasaki disease cases were studied, and changes in incidence and hospitalization rates before and after the COVID-19 outbreak was compared.

RELATED REPORTS

Vaccination boosted immunity acquired from previous SARS-CoV-2 infection

Single-dose Ad26.COV2.S vaccine provides moderate protection against Covid-19 related outcomes

BNT162b2 safe and efficacious in children 5 to 11 years of age

A significant rise in Kawasaki disease-related hospitalizations was noted from April 2020 (median 6 cases per month, 497% increase, 95% CI 72 to 1082), compared to the past 15 years (median 1.2 cases per month, IQR 1.1 to 1.3). In contrast to the increase in cases of Kawasaki disease, a decrease in total hospitalizations was noted from March 2020 to April 2020 (360 hospital admissions per month, 31% decrease, 95% CI -42 to -18). Among 10 individuals diagnosed with Kawasaki disease from April 15 to May 20, 8 (80%) tested positive for COVID-19. These patients ranged from 18 months to 15.8 years of age. Additionally, 6 (60%) children had cardiac abnormalities (1 with coronary aneurysm and 5 with myocarditis). In comparison to the spike in Kawasaki disease hospitalizations linked with COVID-19, the H1N1 outbreak was less severe (median 6 cases per month, 365% increase, 95% CI 31 to 719). Overall, this article highlights the need for healthcare institutions to prepare for an possible influx of patients with Kawasaki disease amidst the COVID-19 pandemic.

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: CoronaviruskawasakiKawasaki diseasepediatricsSARS-CoV-2
Previous Post

Life’s Simple 7 and Incident Hypertension: The REGARDS Study

Next Post

Opportunistic screening for atrial fibrillation not associated with improved diagnostic rates compared to standard care

RelatedReports

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

Vaccination boosted immunity acquired from previous SARS-CoV-2 infection

May 13, 2022
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

Single-dose Ad26.COV2.S vaccine provides moderate protection against Covid-19 related outcomes

May 13, 2022
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

BNT162b2 safe and efficacious in children 5 to 11 years of age

May 13, 2022
Masks for personal protection for SARS-CoV-2 infection
Chronic Disease

Adding mask recommendation did not significantly reduce the SARS-CoV-2 infection rate

May 13, 2022
Next Post
Propofol appears safe and effective in procedural sedation for cardioversion

Opportunistic screening for atrial fibrillation not associated with improved diagnostic rates compared to standard care

#VisualAbstract: Healthcare workers at higher risk of COVID-19 compared to the general population

#VisualAbstract: Healthcare workers at higher risk of COVID-19 compared to the general population

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation

Sleep quality and duration associated with blood uric acid levels

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma
  • Virtual yoga and meditation intervention may be associated with increased health-related quality of life
  • Wellness Check: Mental Health
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.